Is GSN significant for hip BMD in female Caucasians?

Bone

Volumn 63, Issue , 2014, Pages 69-75

  Deng, Fei Yan ^a,b   Zhu, Wei ^b,c   Zeng, Yong ^b,c   Zhang, Ji Gang ^b   Yu, Na ^b   Liu, Yao Zhong ^b   Liu, Yong Jun ^b   Tian, Qing ^b   Deng, Hong Wen ^b,c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b TULANE UNIVERSITY   (United States)

^c HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Bone mineral density; Gelsolin; Integration analysis; Monocyte

Indexed keywords

GELSOLIN; MESSENGER RNA; PROTEOME;

ADULT; ARTICLE; BONE DENSITY; CAUCASIAN; CHINESE; COHORT ANALYSIS; DOWN REGULATION; ETHNICITY; FEMALE; GELSOLIN GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HIP; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONOCYTE; OSTEOCLAST; PREMENOPAUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY;

ADULT; BONE DENSITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GELSOLIN; HIP JOINT; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE;

EID: 84896105203     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.02.015     Document Type: Article

References (51)

1. Sun L., Tan L.J., Lei S.F., Chen X.D., Li X., Pan R., et al. Bivariate genome-wide association analyses of femoral neck bone geometry and appendicular lean mass. PLoS One 2011, 6:e27325.
2. Melton L.J. Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 2003, 18:1139-1141.
3. Jordan K.M., Cooper C. Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol 2002, 16:795-806.
4. Pulkkinen P., Partanen J., Jalovaara P., Jamsa T. Combination of bone mineral density and upper femur geometry improves the prediction of hip fracture. Osteoporos Int 2004, 15:274-280.
5. Riggs B.L., Melton L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995, 17:505S-511S.
6. Iki M. Difference in osteoporosis in men and women. Clin Calcium 2011, 21:1377-1383.
7. Lauritzen J.B. Hip fractures: incidence, risk factors, energy absorption, and prevention. Bone 1996, 18:65S-75S.
8. Nguyen T.V., Howard G.M., Kelly P.J., Eisman J.A. Bone mass, lean mass, and fat mass: same genes or same environments?. Am J Epidemiol 1998, 147:3-16.
9. Deng H.W., Stegman M.R., Davies K.M., Conway T., Recker R.R. Genetic determination of variation and covariation of peak bone mass at the hip and spine. J Clin Densitom 1999, 2:251-263.
10. Recker R.R., Deng H.W. Role of genetics in osteoporosis. Endocrine 2002, 17:55-66.
11. Jian W.X., Long J.R., Li M.X., Liu X.H., Deng H.W. Genetic determination of variation and covariation of bone mineral density at the hip and spine in a Chinese population. J Bone Miner Metab 2005, 23:181-185.
12. Horowitz M.C., Xi Y., Wilson K., Kacena M.A. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001, 12:9-18.
13. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
14. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
15. Quinn J.M., Neale S., Fujikawa Y., McGee J.O., Athanasou N.A. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998, 62:527-531.
16. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T., et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 1990, 87:7260-7264.
17. Matayoshi A., Brown C., DiPersio J.F., Haug J., Abu-Amer Y., Liapis H., et al. Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci U S A 1996, 93:10785-10790.
18. Bar-Shavit Z. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 2007, 102:1130-1139.
19. Cohen-Solal M.E., Graulet A.M., Denne M.A., Gueris J., Baylink D., de Vernejoul M.C. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 1993, 77:1648-1653.
20. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996, 11:1043-1051.
21. Nathan C.F. Secretory products of macrophages. J Clin Invest 1987, 79:319-326.
22. Zhang H., Recker R., Lee W.N., Xiao G.G. Proteomics in bone research. Expert Rev Proteomics 2010, 7:103-111.
23. Deng F.Y., Lei S.F., Zhang Y., Zhang Y.L., Zheng Y.P., Zhang L.S., et al. Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics 2011, 10(M111):011700.
24. Silva J.C., Gorenstein M.V., Li G.Z., Vissers J.P., Geromanos S.J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 2006, 5:144-156.
25. Deng F.Y., Lei S.F., Chen X.D., Tan L.J., Zhu X.Z., Deng H.W. An integrative study ascertained SOD2 as a susceptibility gene for osteoporosis in Chinese. J Bone Miner Res 2011, 26:2695-2701.
26. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
27. Seo J., Hoffman E.P. Probe set algorithms: is there a rational best bet?. BMC Bioinformatics 2006, 7:395.
28. Qu Y., He F., Chen Y. Different effects of the probe summarization algorithms PLIER and RMA on high-level analysis of Affymetrix exon arrays. BMC Bioinformatics 2010, 11:211.
29. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909.
30. Guo Y., Tan L.J., Lei S.F., Yang T.L., Chen X.D., Zhang F., et al. Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet 2010, 6:e1000806.
31. Singer J.B. Candidate gene association analysis. Methods Mol Biol 2009, 573:223-230.
32. Zhang L.S., Hu H.G., Liu Y.J., Li J., Yu P., Zhang F., et al. A follow-up association study of two genetic variants for bone mineral density variation in Caucasians. Osteoporos Int 2012, 23:1867-1875.
33. Tyekucheva S., Marchionni L., Karchin R., Parmigiani G. Integrating diverse genomic data using gene sets. Genome Biol 2011, 12:R105.
34. Wang K., Li M., Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007, 81:1278-1283.
35. Urbanucci A., Waltering K.K., Suikki H.E., Helenius M.A., Visakorpi T. Androgen regulation of the androgen receptor coregulators. BMC Cancer 2008, 8:219.
36. Mosekilde L., Eriksen E.F., Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990, 19:35-63.
37. Michael H., Harkonen P.L., Vaananen H.K., Hentunen T.A. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 2005, 20:2224-2232.
38. Cutolo M., Capellino S., Montagna P., Ghiorzo P., Sulli A., Villaggio B. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res Ther 2005, 7:R1124-R1132.
39. Cutolo M., Sulli A., Craviotto C., Felli L., Pizzorni C., Seriolo B., et al. Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. Ann N Y Acad Sci 2002, 966:204-210.
40. Chang C.S., Kokontis J., Liao S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988, 240:324-326.
41. Lubahn D.B., Joseph D.R., Sullivan P.M., Willard H.F., French F.S., Wilson E.M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988, 240:327-330.
42. Chang C.S., Kokontis J., Liao S.T. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A 1988, 85:7211-7215.
43. Jenster G., van der Korput H.A., Trapman J., Brinkmann A.O. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 1995, 270:7341-7346.
44. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989, 59:477-487.
45. He B., Kemppainen J.A., Voegel J.J., Gronemeyer H., Wilson E.M. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem 1999, 274:37219-37225.
46. Bevan C.L., Hoare S., Claessens F., Heery D.M., Parker M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 1999, 19:8383-8392.
47. Nishimura K., Ting H.J., Harada Y., Tokizane T., Nonomura N., Kang H.Y., et al. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 2003, 63:4888-4894.
48. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999, 274:33179-33182.
49. Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 2004, 61:2614-2623.
50. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999, 11:103-108.
51. Chellaiah M., Kizer N., Silva M., Alvarez U., Kwiatkowski D., Hruska K.A. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 2000, 148:665-678.